Clinical Trials Directory

Trials / Completed

CompletedNCT04970199

Cardiovascular Protective Role of Laser Acupuncture in Systemic Lupus

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Cairo University · Academic / Other
Sex
Female
Age
18 Years – 47 Years
Healthy volunteers
Not accepted

Summary

Systemic lupus erythematosus is a chronic and multisystemic autoimmune disorder which predominantly affecting women. The most common cause of death in lupus patients affected by disease for more than 5 years is cardiovascular disease due to presence of some factors as oxidative stress, pro-inflammatory cytokines , dyslipidemia, diabetes, and hypertension.

Detailed description

laser acupuncture (active or sham) for one month (3 days/week ) on acupoint number 14 of GV meridian, acupoint number 4 and 11 of large intestine, acupoint number 34 of gall bladder meridian, acupoint number 3 of liver meridian, acupoint number 4, 12, and 9 of conception vessel meridian, acupoint number 40, 36, and 25 of stomach meridian, acupoint number 6 of spleen meridian, and acupoint number 5 of triple energizer meridian (laser will be applied for 1 min on every acupiont) in lupus females

Conditions

Interventions

TypeNameDescription
DEVICElaser application on acupointslaser acupuncture

Timeline

Start date
2021-07-12
Primary completion
2021-11-10
Completion
2021-11-30
First posted
2021-07-21
Last updated
2022-01-28

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04970199. Inclusion in this directory is not an endorsement.